| Literature DB >> 27005779 |
Maria da Conceição Pereira1, Sara Morais1, Jorge Sequeiros2, Isabel Alonso3.
Abstract
Variants in CACNA1A that encodes the pore-forming α1-subunit of human voltage-gated Cav2.1 (P/Q-type) Ca(2+)channels cause several autosomal-dominant neurologic disorders, including familial hemiplegic migraine type 1, episodic ataxia type 2, and spinocerebellar ataxia type 6. To identify modifiers of incoordination in movement disorders, we performed a large-scale functional RNAi screen, using the Caenorhabditis elegansstrain CB55, which carries a truncating mutation in the unc-2gene, the worm ortholog for the human CACNA1A The screen was carried out by the feeding method in 96-well liquid culture format, using the ORFeome v1.1 feeding library, and time-lapse imaging of worms in liquid culture was used to assess changes in thrashing behavior. We looked for genes that, when silenced, either ameliorated the slow and uncoordinated phenotype of unc-2, or interacted to produce a more severe phenotype. Of the 350 putative hits from the primary screen, 37 genes consistently showed reproducible results. At least 75% of these are specifically expressed in the C. elegansneurons. Functional network analysis and gene ontology revealed overrepresentation of genes involved in development, growth, locomotion, signal transduction, and vesicle-mediated transport. We have expanded the functional network of genes involved in neurodegeneration leading to cerebellar ataxia related to unc-2/CACNA1A, further confirming the involvement of the transforming growth factor β pathway and adding a novel signaling cascade, the Notch pathway.Entities:
Keywords: RNAi screen; disease modifiers; enhancer/suppressor; unc-2
Mesh:
Substances:
Year: 2016 PMID: 27005779 PMCID: PMC4811018 DOI: 10.1177/1759091416637025
Source DB: PubMed Journal: ASN Neuro ISSN: 1759-0914 Impact factor: 4.146
Figure 1.RNAi screen workflow. On the first day (Day 0), a 96-well plate was inoculated with the RNAi bacterial clones, and the CB55 eggs are extracted by bleaching gravid worms. The larvae then hatched overnight, and in the absence of food, they arrest at the L1-stage. Next day (Day 1), after induction of RNAi expression, each bacterial clone is fed to approximately five synchronous worms, which during the period of incubation grow and lay eggs. On Day 7, the progeny has hatched, and each well is imaged for 30 s to record their movement.
ORF = open reading frame.
Figure 2.Graphical representation of the CellHTS2 score results series of the primary screen. Data analysis using CellHTS2 revealed a mean score distribution around 1.005 ± 0.438, that is, ≥ 95% of the RNAi tested had no effect over the CB55 phenotype. Genes were considered preliminary RNAi hits, when scoring at least two standard deviations away from the mean (highlighted by the dashed line). At this stage, the screen yielded 676 putative RNAi hits.
Genetic Enhancers and Suppressors of the unc-2 Motor Phenotype.
| Group | Gene | Thrashing rate (score) | Expression | Protein | |
|---|---|---|---|---|---|
| N2 (3.3) | CB55 (0.7) | ||||
| I | − (0.0) | − (0.6) | N/A | NCBP-1 – Nuclear Cap-Binding Protein, orthologous to human NCBP1 | |
| II | = (4.0) | − (0.0) | Nervous system | VPS-45 – Related to yeast Vacuolar Protein Sorting factor | |
| M57.2 | = (3.7) | − (0.0) | N/A | N/A | |
| = (4.1) | − (0.5) | Nervous system | SNR-5 – Small Nuclear Ribonucleoprotein | ||
| III | + (5.1) | − (0.2) | Seam cell | CDC-6 – Cell Division Cycle related | |
| + (3.4) | − (0.4) | Gonad | XPF-1 – (Xeroderma Pigmentosum group F) DNA repair gene homolog | ||
| + (4.2) | − (0.2) | Head neurons | NPAX-1 – N-terminal PAX (PAI domain only) protein | ||
| + (4.9) | − (0.2) | N/A | SAGO-2 – Synthetic secondary siRNA-deficient ArGOnaute mutant | ||
| + (4.6) | − (0.1) | Nervous system | TOP-1 – TOPoisomerase | ||
| + (4.2) | − (0.0) | Marginal cell | KLP-3 – Kinesin-Like Protein | ||
| + (4.1) | − (0.1) | Nervous system | DBL-1 – DPP/BMP-Like | ||
| + (6.2) | − (0.0) | N/A | SEC-8 – yeast SEC homolog | ||
| Y47G6A.19 | + (4.4) | − (0.1) | N/A | Y47G6A.19 – orthologous to human carboxypeptidase A and B | |
| + (5.6) | − (0.1) | N/A | PPFR-4 – Protein Phosphatase Four Regulatory subunit | ||
| + (4.4) | − (0.2) | Oocytes | APH-2 – ortholog of nicastrin | ||
| IV | − (0.0) | = (0.6) | Nervous system | UNC-97 – LIM domain-containing protein of the PINCH family | |
| V | − (1.4) | + (1.4) | Head neurons | EGL-43 – Zinc finger protein | |
| − (1.1) | + (1.8) | Nervous system | CEH-21 – | ||
| VI | = (3.5) | + (0.9) | ASI neurons | TGF-β | |
| = (3.2) | + (1.3) | Head neurons | TBX-38 – T box transcription factor | ||
| = (3.1) | + (1.4) | Nervous system | PRX-5 – ortholog of the human receptor for type I peroxisomal targeting signal protein | ||
| K10C3.5 | = (3.1) | + (2.2) | N/A | K10C3.5 – ortholog of budding yeast Ria1p/Efl1p and human EFTUD1 | |
| = (3.2) | + (0.9) | Nervous system | UNC-43 – ortholog of type II calcium/calmodulin-dependent protein kinase (CaMKII) | ||
| = (3.3) | + (101) | Reproductive system, hypodermis, rectal epithelium | PAT-12 – Paralysed Arrest at Twofold | ||
| = (3.4) | + (0.9) | N/A | SEDL-1 – human SEDL (spondyloepiphyseal dysplasia tarda) related | ||
| Y54E10A.10 | = (3.1) | + (1.7) | N/A | N/A | |
| = (3.1) | + (1.0) | Nervous system | UNC-51 – serine/threonine protein kinase orthologous to | ||
| = (3.4) | + (2.2) | Head neurons | SMA-2 – orthologous to Smad1 | ||
| VII | + (4.6) | + (1.3) | Nerve ring | FLP-4 – FMRF-Like Peptide | |
| + (4.9) | + (0.9) | Seam cell | NHR-74 – Nuclear Hormone Receptor family | ||
| + (4.9) | + (1.0) | ASI neurons | SMA-6 – serine/threonine protein kinase orthologous to type I TGF-β receptor | ||
| + (4.0) | + (0.9) | Nerve ring, AVJ, RIV | DAF-14 – orthologous to Smad2 | ||
| + (7.1) | + (0.9) | N/A | nkcc-1 – Na-K-Cl Cotransporter homolog | ||
| R107.5 | + (5.5) | + (.09) | N/A | N/A | |
| + (5.0) | + (1.5) | ASEL, ADF, BDU, ASH, PQR | NTR-1 – NemaTocin Receptor, orthologous to the human vasopressin receptor type 2 | ||
| + (4.1) | + (0.9) | N/A | PQN-85 – Prion-like-(Q/N-rich)- domain-bearing protein, orthologous to human NIPBL | ||
| Y51H1A.3 | + (4.1) | + (0.9) | N/A | Y51H1A.3 – orthologous to human NDUFB8 | |
Note. Motor function: (+) improved, (=) no change, and (−) worsened; N/A = information not available; TGF = Transforming growth factor β: DPP/BMP=Bone morphogenic protein.
Figure 3.Gene network of enhancer and suppressor genes of the unc-2 phenotype. The top 40 genes related to those 37 identified in the genetic screen were plotted using Cytoscape v3.3.1 and GeneMANIA App, which allowed for the network generation according to GO term enrichment analysis and gene function prediction. TGF-β and Notch signaling cascades were the main pathways to be identified by the genetic screen as involved in modulating unc-2 lethargy. Black-colored circles depict direct hits from the screen, while gray-colored ones represent the 40 genes most related to hits, sized according to their weight in the network. The significance of the involvement of other genes relating to RNA metabolism and basic cellular metabolic processes, in light of the available data, remains elusive.
TGF-β = transforming growth factor β.
Figure 4.Crosstalk between unc-2 signaling and other cell signaling pathways. Key intracellular mediators of the unc-2, insulin, TGF-β, Notch, TRK, and Wnt pathways are depicted. Pathways identified by black heading are already known modifiers of the unc-2 phenotype, the remaining, colored gray, depict parallel pathways that, at a given point down the cascade, interact with the already established unc-2, insulin, or TGF-β pathways (dashed lines). The unc-2 null allele (CB55) modifier screens support that the majority of genetic modifiers (enhancers or suppressors) are more likely in different parallel pathways like insulin and TGF-β. The figure shows other major cell signaling mechanisms that crosstalk with insulin and TGF-β and may be a source of more unc-2 modifiers.
TGF-β = transforming growth factor β.